Marshall Wace’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-314,873
| Closed | -$1.97M | – | 2882 |
|
|
2025
Q1 | $1.97M | Buy |
314,873
+216,805
| +221% | +$1.36M | ﹤0.01% | 1376 |
|
|
2024
Q4 | $796K | Buy |
+98,068
| New | +$796K | ﹤0.01% | 1710 |
|
|
2024
Q3 | – | Sell |
-112,691
| Closed | -$1.16M | – | 2649 |
|
|
2024
Q2 | $1.16M | Buy |
+112,691
| New | +$1.16M | ﹤0.01% | 1469 |
|
|
2023
Q2 | – | Sell |
-37,096
| Closed | -$265K | – | 2395 |
|
|
2023
Q1 | $265K | Buy |
+37,096
| New | +$265K | ﹤0.01% | 1855 |
|
|
2022
Q3 | – | Sell |
-54,769
| Closed | -$462K | – | 2954 |
|
|
2022
Q2 | $462K | Buy |
54,769
+30,417
| +125% | +$257K | ﹤0.01% | 2165 |
|
|
2022
Q1 | $330K | Sell |
24,352
-7,813
| -24% | -$106K | ﹤0.01% | 2241 |
|
|
2021
Q4 | $632K | Buy |
+32,165
| New | +$632K | ﹤0.01% | 2068 |
|
|
2021
Q3 | – | Sell |
-29,731
| Closed | -$1.01M | – | 2726 |
|
|
2021
Q2 | $1.01M | Sell |
29,731
-84,154
| -74% | -$2.85M | ﹤0.01% | 1399 |
|
|
2021
Q1 | $4.28M | Sell |
113,885
-4,764
| -4% | -$179K | 0.02% | 828 |
|
|
2020
Q4 | $3.94M | Buy |
+118,649
| New | +$3.94M | 0.02% | 607 |
|